SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending as the community discusses recent buying activity and potential for a pump, while also acknowledging its history of volatility.  Some investors express frustration with XCN's price action, particularly its inability to sustain gains amidst broader market movements.  Debate continues around the project's fundamentals and upcoming Goliath testnet, with some questioning its long-term potential.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to its low float and recent price action, sparking community discussion about a potential squeeze. Traders are closely watching key breakout levels, anticipating a significant move if volume increases. The stock's history of rapid gains and recent after-hours activity is fueling speculation and interest.

1 dog can change your life

The 1DOG crypto is trending, with community members highlighting positive chart patterns and increased volume, especially among Phantom Wallet users. There's a strong sense of "meme energy" around the token, with many anticipating a potential moonshot similar to DOGE or SHIB. Community buzz emphasizes joining the "pack" and not missing out.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

ACON is trending due to community speculation about a potential buyout and excitement surrounding its low float, with some anticipating a significant price surge. Community members are actively discussing the company's partnerships and upcoming presentation, while also pointing out concerns about past reverse splits and dilution. The stock's after-hours movement and high short interest are contributing to the heightened interest.

StarHeroes is the first-ever multiplayer space shooter game designed for esports. The game has been developed since 2021 by GameSwift's subsdiary STAR studio, and offers fast-paced multiplayer galactic battles. StarHeroes provides both web3 and web2 modes, making its innovative gameplay accessible to a wide range of players. The web3 mode is based on a single token $STAR as well as NFTs. The $STAR token has the following utilities:  -Purchase of in-game spaceships -Purchase of in-game fuel to increase the number of games that allow a player to earn $STAR  -Leveling-up of the player’s NFT Hero -Purchase of missions for the player’s NFT Hero -Purchase of a feature that reduces mission time for the player’s  NFT Hero -Staking -Airdrop based on the in-game leaderboard -Share in Real Yield from the StarHeroes game -Governance   StarHeroes is currently in closed beta available to a selected number of players. The Early Access version will be launched in Q1 2024, while the full version is scheduled for Q2 2024.

Starbase

Starbase (STAR) is trending amid community excitement, with some linking it to Elon Musk's Starbase and increased chatter on Twitch. Discussions revolve around its utility beyond trading and how to acquire the coin, while some users are pointing out it could be related to other projects.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

ICP is trending as the community debates its future and potential amid discussions around its technology and recent price movements. Some investors express frustration and call it a "scam," while others see its current price as a buying opportunity, citing its underlying technology and AI capabilities. Community members are also closely watching for increased adoption and institutional interest as potential catalysts.

Numeraire

Numeraire is trending as traders discuss its potential, citing its limited supply and connection to AI. The community is speculating on possible price movements, noting the coin's behavior relative to broader market trends like Bitcoin. Some are pointing to its unique use case in crowdsourced machine learning for hedge funds, while others highlight previous price surges.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash ($ZEC) is trending amid discussions about its privacy features and potential for significant price movement, with some community members drawing comparisons to Bitcoin's early days. The focus is on ZEC's limited supply and recent integrations that enable private cross-chain payments, leading to speculation about a possible bull run and increased adoption. Community members are actively debating its potential as a hedge against market manipulation.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is trending as investors discuss its potential expansion into the U.S. e-commerce market, building on its success in South Korea; however, some analysts caution about e-commerce competition and its current valuation. The community is actively evaluating options strategies and discussing the company's growth prospects in AI and international markets.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

TER is trending as options activity surges, with investors focusing on longer-term call options, particularly for late 2025. Despite some analysts updating ratings, the stock is seeing increased interest in the robotics and AI aspects of the company's business model, as well as its potential within the semiconductor testing industry. Some community members are discussing potential acquisitions and revenue growth, while others are watching for a breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tivic Receives Two Investigational New Drug Applications for Entolimod for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational new drug applications (INDs) for its...

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025...

Shares of Tivic Health Systems, Inc. (TIVC) doubled on Tuesday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.tivichealth.com/tivic-health-reports-white-house-briefing-and-fda-meetings-secured-positive-interest-in-potential-military-and-defense-applications-of-its-product-candidates/">said</a> it has garnered “significant positive interest” in potential military and defense applications for its biologic and bioelectronic product candidates following two meetings held in Washington, D.C.Tivic Health provided briefings to senior leadership at the White House and the Food and Drug Administration (FDA) in Washington, D.C. on April 17th.During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries.Tivic Health’s biopharma program’s lead product candidate, Entolimod, is in late-stage studies for the treatment of acute radiation syndrome.Tivic is also preparing to initiate a phase 2 clinical study for Entolimod for the treatment of Neutropenia, a condition characterized by lower-than-normal levels of neutrophils, a type of white blood cell essential for combating infections.The company also discussed the potential for expedited pathways and support for export opportunities for Entolimod and Tivic’s non-invasive cervical vagus nerve stimulation (ncVNS) technology in a separate meeting with senior leaders of the FDA. &nbsp;Tivic Health’s ncVNS program is advancing medical devices to provide treatments for inflammatory, cardiac, and neurologic disorders.The company said that vagus nerve stimulation has shown “strong potential” in the treatment of post-traumatic stress disorder (PTSD), a neurologic disorder of interest to the military.Tivic CEO Jennifer Ernst said that the meetings were informal in nature and more discussions are expected as the company’s Entolimod and ncVNS medical programs progress toward potential FDA approval.On Stocktwits, retail sentiment around Tivic Health remained bearish over the past 24 hours while message volume remained at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:647/145;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_22_at_12_05_02_PM_png_89e18ee138.webp" alt="TIVC's Sentiment Meter and Message Volume as of 12:05 p.m. ET on April 22, 2025 | Source: Stocktwits" width="647" height="145"><figcaption>TIVC's Sentiment Meter and Message Volume as of 12:05 p.m. ET on April 22, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/TIVC">TIVC stock</a> is up by over 19% so far this year but down by over 65% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-expands-board-adds-aidan-gomez-as-director/chQSuj1RbXk">Rivian Expands Board, Adds Cohere CEO Aidan Gomez As Director: But Retail Stays Bearish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Tivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays Bearish

During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries.

Equity

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today that Michael K. Handley, formerly Chief Executive Officer, President and Chairman of Statera Biopharma...

Shares of The Real Good Food Company ($RGF) dived nearly 65% on Monday as the company announced it received a delisting notice from The Nasdaq, dampening retail sentiment.Real Good Food, a maker of refrigerated foods, said it was no longer in compliance with Nasdaq Listing 5250(c)(1) for failure to file periodic financial reports.Trading in its common stock on Nasdaq will be suspended on January 7.Its common stock is expected to commence trading on the Pink Open Market operated by the OTC Markets Group Inc. (“OTC”), referred to as the “pink sheets,” commencing on January 7.The company warned that trading may ultimately move to OTC’s “Expert Market,” where quotes for the company’s common stock will no longer be available for public viewing.Retail sentiment on Stocktwits seemed bearish with commenters expressing surprise given its recent reverse stock split.<stembedurl>https://stocktwits.com/DisgruntledbutzenDavid/message/599043071</stembedurl>Last month, Real Good Food announced a 12-to-reverse stock split, sparking retail chatter on Stocktwits. According to a company statement, the stock split consisted of its Class A common stock, par value $0.0001, and Class B common stock, par value $0.0001, set to become effective at 5:00 pm ET on January 3. The stock split was to affect all holders of its common stock uniformly, the company said.Real Good Food posted a loss per share of $0.50 for its third quarter, compared to the $0.20 that analysts expected.Real Good Food stock is down nearly 70% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Real Good Food Stock Dives On Nasdaq Delisting: Retail Mood Sours 

The company warned that trading may ultimately move to OTC’s “Expert Market,” where quotes for the company’s common stock will no longer be available for public viewing.

CEO Letter to Shareholders Issued by Tivic Health

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, today released its annual CEO letter to shareholders. Dear Fellow Shareholders...

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months ended September, 30, 2024...

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization...

Tivic Health Validates European Patents in Great Britain, Germany, and France

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicinal devices, announced today that it has validated two granted European Patent...

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it will report financial results on Thursday, November 14...

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Fremont, CA.

Tivic Health Systems Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$2.89
Prev Close	$2.96
Open	$2.95
Dividend Yield	0.00%
50-Day Moving Average	$3.12
Beta	0.93
Avg. Volume	105,032.38
PE Ratio	-0.26

52-Week High	$15.64
52-Week Low	$2.43
Market Capitalization	$4.55M
EPS (Annual)	-$19.68
Price to Book	0.76
Revenue Per Employee	$86,666.67
Enterprise Value/EBITDA	N/A

TIVC
Tivic Health Systems Inc

Feed

News

Sentiment

Fundamentals

Info

Latest TIVC News

TIVCTivic Health Systems Inc